Skip to main content

Table 1 Clinical characteristics of S. agalactiae invasive infections in non-pregnant adults 2004 – 2012

From: Emerging trends in invasive and noninvasive isolates of Streptococcus agalactiaein a Latin American hospital: a 17-year study

  Total Invasive infections n = 57 n (%) Female n = 21 n (%) Male n = 36 n (%) Bloodstream Infections n = 34 n (%)
Female 21 (36.8)    12 (35.3)
Male 36 (63.2)    22 (64.7)
≥60 y.o 25 (43.9) 8 (38) 15 (42) 18 (53)
Mean   53 y. o. 55 y. o.  
Range   [17–82] [24–83]  
In-hospital fatality 10 (17.5) 3 (14.3) 6 (16.7) 7 (20.6)
Polymicrobial infections 13 (22.8) 2 (9.5) 11 (31) 7 (20.6)
Bloodstream infections 34 (59.7) 12 (57.1) 22 (61.1)  
Underlying conditions     
Cancer 14 (24.6) 8 (38) 6 (16.7) 10 (29.4)
-Hematologic malignancies 7 (12.3) 4 (19) 3 (8.3) 5 (14.7)
Diabetes 16 (28) 6 (28.6) 10 (27.8) 7 (20.6)
Transplant 4 (7) - 2 (5.6) 1 (2.9)
Cirrhosis/liver disorder 4 (7) 1 (4.8) 3 (8.3) 3 (8.8)
Renal disorder 7 (12.3) 1 (4.8) 2 (5.6) 3 (8.8)
Lung disease 3 (5.3) 2 (9.5) 2 (5.6) 2 (5.9)
HIV 3 (5.3) - 3 (8.3) 1 (2.9)
Autoimmune disorder 3 (5.3) 1 (4.8) 1 (2.8) 3 (8.8)
Other 3 (5.3) 2 (9.5) 2 (5.6)* 2 (5.9)**
More than one underlying condition 20 (35) 6 (28.6) 14 (38.9) 13 (38.2)
Portal of entry     
Primary bacteremia     14 (41.2)
Skin and soft tissue     8 (23.5)
Respiratory tract     7 (20.6)
Gastrointestinal tract     4 (11.8)
Urinary tract     1 (2.9)
  1. y.o: years old.
  2. *No underlying condition was identified in 5 cases.
  3. **No underlying condition was identified in 2 bloodstream infections.